Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by woundedkneeon Jul 24, 2023 5:47am
125 Views
Post# 35553794

RE:RE:RE:RE:Just read

RE:RE:RE:RE:Just readMrM...My losses are merely symbolic of what could have been prevented if proper and more intensive steps were taken. You seen to forget I have come to your defence on a number of occasions in the past and just because there is a difference of opinion you seem resentful and even defensive at times. It's laughable when you're basically saying that I should have known about the liver enzymes. I think the answer to that is fairly obvious. Either directly or indirectly, mangement indicated that would not be a problem so don't shift that to me or others, (including yourself) who were confident in management's earlier position regarding that question.
Yes Sireee, I was here to make money on a stock that was touted to as much as triple in value and I cannot believe you would criticize that decision. You would never get a job with Warren Buffett. Oh right, you don't invest in a market. What a ridiculous statement. And believe me, I answered your post to comment on your remarks it was not about you as an individual, Now it's obvious your investment strategy is your own and far be it from me to disagree with that. Kudos for your beliefs and staying with a company that most original holders have long deserted. This has not, nor ever was personal. You have never struck me as having anything but good intentions, even though some may be flawed at times. Have a great day and good luck with your "non market" investments.

<< Previous
Bullboard Posts
Next >>